What causes wmh

Overview

White matter hyperintensities (WMH), also known as leukoaraiosis, are a common finding on magnetic resonance imaging (MRI) of the brain. They appear as bright spots on T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequences, indicating areas of damage or abnormality within the brain's white matter. White matter consists of nerve fibers (axons) that are covered by a myelin sheath, a fatty substance that helps to speed up the transmission of nerve signals. WMH represent a loss of myelin, axonal damage, or increased water content in these areas. While often associated with aging and cerebrovascular disease, their causes are diverse, and they can have significant implications for cognitive function and overall brain health.

What is White Matter?

The brain is broadly divided into gray matter and white matter. Gray matter contains nerve cell bodies (neurons), dendrites, and unmyelinated axons, and is primarily involved in processing information. White matter, on the other hand, is composed of myelinated axons, which act like insulated wires connecting different areas of gray matter. The myelin sheath, typically made of lipids and proteins, allows for rapid and efficient communication between neurons. Damage to this white matter can disrupt these communication pathways.

Causes of White Matter Hyperintensities (WMH)

The development of WMH is multifactorial, but several key factors are consistently implicated:

1. Aging and Normal Pressure Hydrocephalus (NPH):

As individuals age, the brain undergoes natural changes, and the small blood vessels within it can become less efficient. This can lead to chronic ischemia (reduced blood flow) and damage to the white matter. WMH are very common in older adults, with their prevalence and extent generally increasing with age. Studies have shown that over 90% of individuals over the age of 70 have some degree of WMH. While aging is a primary driver, WMH can also be exacerbated by other conditions.

2. Cerebrovascular Disease (Small Vessel Disease):

This is perhaps the most significant cause of WMH. Small vessel disease refers to pathological changes in the small arteries, arterioles, capillaries, and venules of the brain. Chronic hypertension (high blood pressure) is a major contributor to small vessel disease. High blood pressure damages the walls of these small vessels, making them stiff and narrow, which impairs blood flow and can lead to micro-infarcts (tiny strokes) and leakage of fluid into the surrounding white matter. Other vascular risk factors that contribute to small vessel disease and WMH include:

• Diabetes mellitus
• High cholesterol (dyslipidemia)
• Smoking
• Obesity
• Atrial fibrillation and other cardiac conditions
• History of stroke or transient ischemic attack (TIA)

These conditions collectively lead to a state of chronic hypoperfusion and microvascular damage, resulting in the characteristic lesions seen as WMH on MRI.

3. Inflammatory and Demyelinating Diseases:

Certain autoimmune and inflammatory conditions can directly target the myelin sheath, leading to demyelination and the formation of WMH. The most prominent example is Multiple Sclerosis (MS). In MS, the immune system mistakenly attacks the myelin in the central nervous system, causing lesions that appear as WMH on MRI. Other inflammatory conditions, though less common, can also cause similar changes.

4. Migraine:

There is a growing body of evidence suggesting a link between migraine headaches and the presence of WMH. While the exact mechanism is not fully understood, theories suggest that migraine attacks may involve temporary changes in blood flow or inflammatory processes that could contribute to white matter damage over time. Individuals with a history of migraine, particularly those with aura, may have a higher risk of developing WMH compared to the general population.

5. Genetic Factors and Other Causes:

Some rare genetic disorders can affect white matter development or maintenance, leading to WMH. These include leukodystrophies, which are a group of inherited metabolic disorders that affect white matter. Additionally, certain infections, metabolic disturbances, and even some medications have been implicated in the development of WMH, although these are less common causes.

Symptoms Associated with WMH

Often, WMH are asymptomatic and are discovered incidentally during an MRI scan performed for an unrelated reason. However, when WMH are extensive or located in critical areas of the brain, they can be associated with a range of symptoms, including:

• Cognitive decline, including problems with memory, attention, and executive function (planning, organizing)
• Mood changes, such as depression or apathy
• Gait disturbances and balance problems
• Urinary incontinence (in the context of Normal Pressure Hydrocephalus)

The presence and severity of symptoms often correlate with the burden of WMH and the underlying cause.

Diagnosis and Management

WMH are diagnosed through neuroimaging, primarily MRI. The pattern, location, and extent of the hyperintensities help clinicians infer potential causes. Management focuses on addressing the underlying risk factors. For WMH related to small vessel disease, aggressive control of hypertension, diabetes, and cholesterol, along with smoking cessation and weight management, is crucial. For conditions like MS, specific disease-modifying therapies are used. Currently, there is no specific treatment to reverse existing WMH, but preventing further damage through risk factor modification is the primary goal.